Early research (Phase 1)Ended earlyNCT02601378What this trial is testingA Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma.Who this might be right forUveal Melanoma Novartis Pharmaceuticals 107
Early research (Phase 1)Ended earlyNCT07076550What this trial is testingA Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic MelanomaWho this might be right forMelanoma MetastaticUveal Melanoma, MetastaticMucosal Melanoma Alpha-9 Oncology USA Inc. 5
Early research (Phase 1)Study completedNCT05004025What this trial is testingSingle Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal MelanomaWho this might be right forUveal Melanoma HonorHealth Research Institute 10
Testing effectiveness (Phase 2)Study completedNCT01200238What this trial is testingSTA-9090(Ganetespib) in Metastatic Ocular MelanomaWho this might be right forOcular Melanoma Dana-Farber Cancer Institute 17
Not applicableLooking for participantsNCT01438658What this trial is testingAssessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal MelanomaWho this might be right forUveal Melanoma Hadassah Medical Organization 250
Testing effectiveness (Phase 2)Active Not RecruitingNCT03467516What this trial is testingAdoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal MelanomaWho this might be right forUveal NeoplasmsMelanoma, Uveal Udai Kammula 34
Testing effectiveness (Phase 2)WithdrawnNCT04184518What this trial is testingDurvalumab (MEDI4736) Plus Cediranib in Patients With Metastatic Uveal MelanomaWho this might be right forUveal MelanomaMetastatic Cancer Grupo Español Multidisciplinar de Melanoma
Early research (Phase 1)Ended earlyNCT04879017What this trial is testingFHD-286 in Subjects With Metastatic Uveal MelanomaWho this might be right forMetastatic Uveal Melanoma Foghorn Therapeutics Inc. 76
Early research (Phase 1)Study completedNCT01430416What this trial is testingSafety and Efficacy of AEB071 in Metastatic Uveal Melanoma PatientsWho this might be right forUveal Melanoma Novartis Pharmaceuticals 153
Not applicableNo Longer AvailableNCT01728051What this trial is testingExpanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to LiverWho this might be right forMetastatic Liver CancerOcular MelanomaCutaneous Melanoma Delcath Systems Inc.
Large-scale testing (Phase 3)Study completedNCT00324727What this trial is testingHepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to MelanomaWho this might be right forIntraocular MelanomaMelanoma (Skin)Metastatic Cancer Delcath Systems Inc. 93
Testing effectiveness (Phase 2)Active Not RecruitingNCT04728633What this trial is testingTransarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver MetastasesWho this might be right forMetastatic Malignant Neoplasm in the LiverMetastatic Uveal MelanomaStage IV Choroidal and Ciliary Body Melanoma AJCC V8 Thomas Jefferson University 28
Testing effectiveness (Phase 2)Ended earlyNCT01533948What this trial is testingAxitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by SurgeryWho this might be right forExtraocular Extension MelanomaMetastatic Intraocular MelanomaRecurrent Intraocular Melanoma+9 more Roswell Park Cancer Institute 25
Testing effectiveness (Phase 2)WithdrawnNCT03326258What this trial is testingGlembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by SurgeryWho this might be right forAdvanced Malignant Solid NeoplasmEstrogen Receptor NegativeGPNMB Positive+15 more National Cancer Institute (NCI)
Early research (Phase 1)Ended earlyNCT04935229What this trial is testingIntrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal MelanomaWho this might be right forMetastatic Uveal Melanoma in the Liver TriSalus Life Sciences, Inc. 67
Early research (Phase 1)Looking for participantsNCT05607095What this trial is testingLN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or AngiosarcomaWho this might be right forUveal MelanomaMelanomaMetastatic Uveal Melanoma+1 more Memorial Sloan Kettering Cancer Center 40
Testing effectiveness (Phase 2)Looking for participantsNCT06626516What this trial is testingTebentafusp-tebn With LDT in Metastatic UMWho this might be right forMetastatic Uveal Melanoma Thomas Jefferson University 109
Testing effectiveness (Phase 2)Active Not RecruitingNCT04802876What this trial is testingEfficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing TumorsWho this might be right forMSI-H Colorectal CancerMelanomaAnal Carcinoma+28 more SOLTI Breast Cancer Research Group 184
Very early researchEnded earlyNCT00499733What this trial is testingCyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Study completedNCT02158520What this trial is testingNab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by SurgeryWho this might be right forMetastatic MelanomaMucosal MelanomaStage IV Cutaneous Melanoma AJCC v6 and v7+2 more Academic and Community Cancer Research United 24